Barron's: ABT Stock Offers a 20% Return

Read why Barron's predicts strong growth for Abbott shareholders.

Strategy and Strength|Feb.23, 2017

By investing in areas that are aligned with healthcare trends, Abbott is well-positioned for growth for many years to come. In fact, in a recent Barron’s article, the publication noted that "with a 2.5% dividend included, [Abbott] could provide a 20% total return within 12 months."

Click to read more from Barron's and see what Abbott Chairman and CEO Miles D. White and others had to say about the company in 2017.